conference programme - collège des … european conference on health economics collÈge des...

FOURTH EUROPEAN CONFERENCEON HEALTH ECONOMICS

COLLÈGE DES ÉCONOMISTESDE LA SANTÉ

Q U ATRIÈME COLLOQUE EUROPÉEND’ÉCONOMIE DE LA SANTÉ

Paris 20027-10 July 20027-10 juillet 2002Université Paris VRené DescartesParis - France

CONFERENCE PROGRAMME

F O U R T HEUROPEAN CONFERENCE ON HEALTH ECONOMICS

7 – 10 JULY 2002

UNIVERSITÉ PARIS V RENÉ DESCARTES45, RUE DES SAINTS-PÈRES

PARIS 75006 F R A N C E


€

ContentsConference Organisers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Welcome message . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

Social Events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

4th ECHE “at a glance” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Key to Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Pre-conference Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

Scientific Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9Monday 8 July 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9Tuesday 9 July 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15Wednesday 10 July 2002. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22

Index of Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

Please note : The session identifier numbers in this programme correspond to those in the 4thECHE Book of Abstracts. Some sessions and papers have been re-timed since the Book ofAbstracts was produced, therefore numbers may appear to be out of sequence in thisprogramme. These have not been changed in order to facilitate location of the relevantabstract in the Book of Abstracts.

ORGANISING COMMITTEEGérard de Pouvourville – CREGAS – INSERM (France) –ChairAriel Béresniak – ARES SERONO (Switzerland)Martine Bungener – CNRS CERMES (France)Benoît Dervaux – CRESGE (France)Gérard Duru – Université Lyon I (France) Francis Fagnani – CEMKA (France)Maryse Gadreau – Université de Bourgogne (France) Michel Grignon – CREDES (France)Pierre-Jean Lancry – CNAMTS (France) Robert Launois – Université Paris Nord (France)Claude Le Pen – Univ. Paris IX Dauphine (France)Émile Lévy – Université Paris IX Dauphine (France) Jean-Paul Moatti – INSERM – Univ. Aix-Marseille (France) Philippe Mossé – CNRS – LEST (France) Henry Noguès – Université de Nantes (France)Dominique Polton – CREDES (France) Lise Rochaix-Ranson – GREQAM-IDEP – Marseille (France)Jean-Claude Sailly – CRESGE (France) Simone Sandier – ARgSES (France) Philippe Ulmann – CES – CNAM (Paris, France) –Conference Co-ordinator

SCIENTIFIC COMMITTEEMartin Buxton – Brunel University (UK) Gérard de Pouvourville – CREGAS – INSERM (France) Michael Drummond – University of York (UK) Louis Eeckhoudt – University of Mons (Belgium) George France – Consiglio Nazionale delle Ricerche (Italy) Carlos Gouveia Pinto – Univ. Nova de Lisboa (Portugal) Lászlo Gulácsi – Budapest University (Hungary)Bengt Jönsson – Stockholm School of Economics (Sweden) Reiner Leidl – University of Ulm (Germany) Émile Lévy – Université Paris IX Dauphine (France) Guillem Lopez Casasnovas – Univ. Pompeu Fabra (Spain) Alan Maynard – University of York (UK) Lise Rochaix-Ranson – Univ. Aix-Marseille II (France) Juan Roviera – World Bank (USA) Frans Rutten – Erasmus Univ. Rotterdam (The Netherlands)Harri Sintonen – FOHCTA (Finland) Peter Zweifel - University of Zurich (Switzerland)

CONFERENCE

AKNOWLEDGEMENTSThe conference organisers whish to thank the following organisations for their generous support ofthe conference:

UNDER THE PATRONAGE OF THEFRENCH MINISTRY OF HEALTH

CONFERENCE SPONSORS

4

©

L A B O R A T O I R E S

€

Welcome to The4th European Conference on Health EconomicsOn behalf of the Collège des Économistesde la Santé and of the ScientificCommittee, we are delighted to welcomeyou at the 4th European Conference onHealth Economics, in Paris from July 7 toJuly 10, 2002. After Barcelona (1989), Paris (1992),Stockholm (1995), this Conference willdemonstrate the vitality of health econo-mics research in Europe.It will also be the opportunity to strengthenlinks amongst European teams, at a timewhen more and more the research commu-nity in our continent is expected to colla-borate. The Conference is hosted by the MedicalSchool of University of Paris V, two minutesaway from Saint-Germain des Prés, in oneof the most lively and exciting areas of ourcapital. We hope that you will enjoy both high qua-lity academic work and high quality of life. Bienvenue à Paris!

Gérard de PouvourvilleChair, CES, Organising Committee.

General informationInformation pointThere is an information point in the Central Hall to assistparticipants. In addition a number of conference helperswill be available at all times and will be happy to deal withparticipants queries.

ExhibitionA number of editors and research organisations will beexhibiting materials during the conference in the CentralHall.

MessagesA message board is located in the Central Hall.

Conference badgesEach registered delegate will receive a name badge. Thisshould be worn at all times. Only individuals wearingofficial conference name badges will be admitted to theconference functions and sessions.

SmokingSmoking is not allowed in any of the conference venues.

Meals and refreshmentsCoffee, tea and soft drinks will be available at designedbreaks in the programme in the Central Hall. Lunch will beserved each day between 12.30 and 13.30.

4th European Conference on Health Economics

Paris, 7-10 July 2002

PROGRAMME

Social EventsWelcome and closing cocktailsThere will be a welcome cocktail on Sunday 7 July from 17.00 to 19.00, and a closing cocktail on Wednesday10 July, from 16.30 to 18.00. Both will take place in the Central Hall of the Saints-Pères University Centre –University Paris V - René Descartes (Conference location).

Conference DinnerMonday 8 July will be held the Conference dinner. It will take place at the “Maison des Polytechniciens”, an18th century mansion, located in the heart of the 7th district, at a few minutes from the Conference. The resi-dence was acquired by the "Ecole Polytechnique" Alumni Club in 1930, with a view to make it thePoytechnicians favourite meeting place.

“Bâteau-Mouche”* trip – River Boat cruise(*name given to tourist boats which ply the Seine. Literally translated it means the ``fly boats''). A one-hour“bateau-mouche” cruise is planned on Tuesday, 9th of July, 2002, at the end of the afternoon. The trip will takepassengers in such sights as the Louvre, Notre Dame, Orsay Museum, The Eiffel Tower, and the Statue of Liberty.

5

4th ECHE “at a glance”

Sunday 7 July 2002

13.00 – 19.00 WELCOME AND REGISTRATION

14.00 – 16.30Pre-conference PCS1: HEALTH ECONOMICS IN CENTRAL AND EASTERN EUROPESessions PCS2: ELECTRONIC DATABASES OF HEALTH ECONOMIC EVALUATION

17.00 – 19.00 WELCOME COCKTAIL

Monday 8 July 2002

9.00 – 9.15 Official Welcome AddressesGérard de POUVOURVILLE (Collège des Économistes de la Santé)

9.15 – 10.45 Keynote speakers :Opening Plenary PLS1: Robert BOYERSession PLS2: Xavier SALA-I-MARTIN

10.45 – 11.15 COFFEE BREAK

11.15 – 12.45 OS14: PERFORMANCE MEASUREMENT OF HEALTH CARE ORGANISATIONS Session I PS5: DRUG AND TOBACCO ADDICTION

PS9: ECONOMIC EVALUATION STUDY IPS12: HEALTH CARE DEMANDPS14: HEALTH CARE EXPENDITURE AND AGEINGPS29: PUBLIC/PRIVATE MIX OF HEALTH INSURANCE

12.45 – 13.30 LUNCH

13.30 – 14.30 POS I: POSTER SESSION I

14.30 – 16.00 OS6a: HEALTH CARE SYSTEMS IN TRANSITION – COUNTRIES OF CENTRAL AND EASTERN EUROPE ISession II OS9: RISK ADJUSTMENT IN HEALTH ECONOMICS

PS16: HEALTH CARE SYSTEM PERFORMANCEPS22: HEALTH, HEALTH EXPENDITURE AND ECONOMIC GROWTHPS33: WILLINGNESS-TO-PAY I


16.30 – 18.00 OS6b: HEALTH CARE SYSTEMS IN TRANSITION – COUNTRIES OF CENTRAL AND EASTERN EUROPE IISession III OS8: ECONOMIC EVALUATION AT AN INTERNATIONAL LEVEL

PS1: AXIOMATIC FOUNDATIONS OF OUTCOMES MEASUREMENTPS11: EFFECTS OF SUPPLEMENTARY HEALTH INSURANCE ON HEALTH CARE CONSUMPTIONPS21: HEALTH WORKFORCE PLANNING

19.30 pm CONFERENCE DINNER

CONFERENCE

6

€



PROGRAMME

7

Tuesday 9 July 20029.00 – 10.30 OS2: REGIONAL HEALTH CARE IN A FEDERAL EUROPESession IV OS4: INTEGRATION/COORDINATION IN THE HEALTH CARE SYSTEM

OS16: RISK PERCEPTION AND PREVENTION PS3: COST STUDIESPS23: HOSPITAL FINANCINGPS34: WILLINGNESS-TO-PAY II


11.00 – 12.30 OS5: PRICING AND PATENTING REGULATIONS OF DRUGS IN EUROPESession V OS11: COST OF AGEING AND COST OF DYING

OS12: TAXATION AND ADDICTIONPS2: COMPETITION AND REGULATION OF HEALTH CAREPS25: METHODOLOGY OF PREFERENCE ELICITATIONPS30: REGIONAL HEALTH CARE

12.30 – 13.30 LUNCH

13.30 – 14.30 POS II: POSTER SESSION II

14.30 – 16.00 OS7: BAYESIAN APPROACHSession VI OS10: MICROECONOMIC APPROACHES FOR UNDERSTANDING THE PHYSICIAN-PATIENT ENCOUNTER

OS13: FREE CHOICE OF SICKNESS FUNDS IN REGULATED COMPETITION - EVIDENCE FROM THE NETHERLANDS,GERMANY AND SWITZERLAND

PS6: DRUGS AND REGULATIONPS18: HEALTH IN CENTRAL AND EASTERN EUROPE COUNTRIESPS27: PERFORMANCE MEASUREMENT OF ORGANISATION I


16.30 – 18.00 OS15: EFFECT OF OWNERSHIP AND MANAGEMENT ON PROVIDERS' PERFORMANCESession VII PS7: DRUGS MARKET : STRUCTURE, PRICING AND ADVERTISING

PS15: HEALTH CARE ORGANISATION AND COORDINATIONPS24: METHODOLOGY OF ECONOMIC EVALUATIONPS28: PERFORMANCE MEASUREMENT OF ORGANISATION II : DEA METHODPS31: RISK ADJUSTMENT FOR HEALTH CARE FINANCING

19.00 RIVER BOAT CRUISE

Wednesday 10 July 20029.00 – 10.30 OS3: THE EFFICIENT PRODUCTION OF HEALTH CARE IN EUROPESession VIII PS4: DECISION MAKING, EQUITY AND PRIORITY SETTING IN HEALTH CARE

PS10: ECONOMIC EVALUATION STUDY IIPS17: HEALTH DETERMINANTSPS20: HEALTH PROFESSIONALS AND INCENTIVESPS32: TREATMENT CHOICE AND PROVIDER INCENTIVES


11.00 – 12.30 Keynote speakers :Closing Plenary PLS3: Alain ENTHOVENSession PLS4: Bengt JÖNSSON

12.30 – 13.30 LUNCH

13.30 – 14.30 POS III: POSTER SESSION III

14.30 – 16.00 OS1: PAYMENT TO DOCTORS IN AMBULATORY CARESession IX PS8: DRUGS PRESCRIPTION AND EXPENDITURE

PS13: HEALTH CARE DETERMINANTS, WORK AND LIVING CONDITIONSPS19: HEALTH INSURANCE AND RISK ADJUSTMENTPS26: MICROECONOMIC ANALYSIS OF HEALTH BEHAVIOR

16.00 – 16.30 Presidential Closing SpeechClosing Session Gérard de POUVOURVILLE (Collège des Économistes de la Santé)

16.30 – 18.00 CLOSING COCKTAIL

Key to abbreviationsSession Types

OS Organised SessionPS Parallel SessionPLS Plenary SessionPOS Poster SessionPCS Pre-Conference Session

Each session and paper has a unique identifier.

Rooms

A Bin Amphitheatre Binet, Ground FloorA Del Amphitheatre Delmas, Second FloorA Pol Amphitheatre Polonovski, Second FloorA Wei Amphitheatre Weiss, First FloorCHA Central Hall, Ground FloorRT112 Room T112, First FloorRT208 Room T208, Second FloorRT209 Room T209, Second Floor

Rooms are signposted from the Central hall.

Sunday 7 July 2002

Pre-Conference Sessions

Pre-conference sessions on the afternoon of Sunday 7 July 2002, from 14.00 to 16.30

PCS1 Health Economics in Central and Eastern EuropeA.Wei Chair: László Gulácsi (Budapest University – Hungary) & Malcom Whitfield

(University of Sheffield, UK) – Secretary of session : Agnes Brandmuller & BalázsNagy (Budapest University – Hungary)

PCS2 Electronic databases of health economic evaluation – the NHS EconomicEvaluation Databases, the CODECS database and the EURO NHEED projectA. PolPresenters: John Nixon (NHS Centre for Reviews and Dissemination, University ofYork) & Stéphanie Boulenger (Collège des Économistes de la Santé, Paris)

CONFERENCE

8

€Room

A BinOPENINGPLENARYSESSION

Session

PLS1

PLS2

Keynote speakers

BOYER R (CEPREMAP ENS Paris) :Healthcare Reorganization and the Future of European Growth

SALA-I-MARTIN X (Columbia University & CRES-University Pompeu Fabra) :Economic growth and health



PROGRAMME

Monday 8 July 20029.15 – 10.45

11.15 – 12.45SESSION I

Room Session Title/Chair Paper/Presenting Author, Co-authors

A Wei OS14 PERFORMANCE MEASUREMENTOF HEALTH CAREORGANISATIONS

Chair:LELEU H (CRESGE) &MINVIELLE E(CREGAS-INSERM U537)

DEA-BASED INCENTIVE REGIMES IN HEALTH-CARE PROVISIONAgrell P, Bogetoft P

INSIDE THE BLACK BOX OF HOSPITAL PERFORMANCESicotte C, Champagne F, Contandriopoulos A-P, Geneau R, Bronsard A

DEA-BASED REGULATION: THEORY AND APPLICATION TO INPATIENT CARE INSAXONY-ANHALTFelder S, Schmitt H

RT208 PS5 DRUG AND TOBACCOADDICTION

Chair:LÉVY E(Université Paris IX Dauphine)

CIGARETTE DEMAND : A META-ANALYSIS OF ELASTICITIESGallet C

IT WASN'T ME, IT WAS THEM! A STUDY OF SOCIAL INFLUENCE IN RISKYBEHAVIOUR BY ADOLESCENTSLoheac Y, Clark A

RATIONAL ADDICTION AND IRRATIONAL SUBSTITUTION IN DRUG MAIN-TENANCE TREATMENTS WITH BUPRENORPHINE HIGH DOSAGE IN FRANCEParaponaris A, Moatti J-P, Obadia Y, Perrin V

THE IMPACT OF PRICES ON YOUTH'S TOBACCO INITIATION IN FRANCEPierrard B, Grignon M

A Del PS9 ECONOMIC EVALUATIONSTUDY I

Chair:LE PEN C(Université Paris IX Dauphine)

DETERMINISTIC AND STOCHASTIC COST EFFECTIVENESS ANALYSIS OFCARVEDILOL IN THE TREATMENT OF SWEDISH CHRONIC HEARTH FAILURE(CHF) PATIENTSÖdegaard K, Ghatnekar O, Pearson U, Willis M

ECONOMIC EVALUATION OF ONE-OFF INTERVENTIONS WITH LONG-TERMBENEFITS AND COST CONSEQUENCES: COST-EFFECTIVENESS ANALYSIS OFCOGNITIVE BEHAVIOURAL THERAPY (CBT) FOR PEOPLE WITH SCHIZOPHRENIAMajor K, Sutton M, Abu-Rmeileh N, Gumley A

20 YEAR PROJECTIONS OF TYPE 2 DIABETES COSTS INLANGUEDOC-ROUSSILLONFromentin R, Stephane D

SETTING PRIORITIES FOR RESEARCH: AN APPLICATION TO A CLINICAL TRIALOF VITAMIN D AND CALCIUM SUPPLEMENTATION FOR THE PREVENTION OFFRACTURES IN THE ELDERLYFleurence R

9

CONFERENCE


RT209 PS12 HEALTH CARE DEMAND

Chair:de POUVOURVILLE G(CREGAS – INSERM U537)

DENTIST SERVICE UTILIZATION OF ADULT FINNS: RESULTS FROM THENATIONAL HEALTH-CARE SURVEYNguyen T-T-L, Hakkinen U, Rosenqvist G

DO THE VARIATIONS OF THE SOCIAL AND SPATIAL CHARACTERISTICSOF THE PATIENTS AFFECT THEIR PROFILES OF MEDICAL CONSUMPTION ?Fiszman P, Dehon C

THE IMPACT OF ACCESSIBILITY ON THE USE OF SPECIALIST HEALTH CAREIN NORWAYKopperud G-S, Iversen T

WILLINGNESS-TO-PAY FOR ONLINE PHYSICIAN SERVICESLinnosmaa I, Rissanen S

A Pol PS14 HEALTH CARE EXPENDITURE ANDAGEING

Chair:LEIDL R(University of Ulm)

THE SISYPHUS SYNDROME IN HEALTH REVISITEDZweifel P, Steinmann L

HOSPITAL EXPENDITURE AS FUNCTION OF THE DISTANCE FROM BIRTHAND DEATHCislaghi C, Bartolacci S, Berni R, Forni S, Tediosi F

SIMULATED LONG TERM CARE EXPANDITURE IN SPAIN : DOES AGEINGLEAD TO EXPLOSIVE COSTS ?Costa J, Patxot C, Gemma Abioa J-G

HEALTHY AGEING AND THE DYNAMICS OF HEALTH CARE EXPENDITURE –CAN OECD SOCIAL AND HEALTH CARE SYSTEMS PROVIDE FOR THEFUTURE ?Jacobzone S

A Bin PS29 PUBLIC/PRIVATE MIX OFHEALTH INSURANCE

Chair:LOPEZ CASANOVAS G(University Pompeu Fabra)

CAN THE PUBLIC SECTOR SAVE MONEY BY INCREASING PRIVATE HEALTHCARE COVERAGE?Lopez-Nicolas A, Vera-Hernandez M

HEALTH INSURANCE, COMPETITION AND AUCTIONBardey D

ON THE POLITICAL SUSTAINABILITY OF PUBLIC HEALTH CARE SYSTEMSKifmann M

SUPPLEMENTARY HEALTH INSURANCE AND REVERSE REDISTRIBUTIONUNDER EX-POST MORAL HAZARDLippi Bruni M, Barigozzi F

Monday 8 July 2002

11.15 – 12.45SESSION I

10

€



PROGRAMME

13.30 – 14.30POS I: POSTER SESSION IRoom: CHA

Poster Titre/Presenting Author, co-authors

Poster 1 THE VALIDITY OF WILLINGNESS TO PAYAnker M-M

Poster 2 INTEGRATING COST-EFFECTIVENESS EVIDENCE INTO CLINICAL PRACTICE GUIDELINES IN AUSTRALIA FOR RESPIRATORY AND CARDIOLOGY: INSIGHTS FOR EUROPEAND NORTH AMERICAAntioch K, Jennings Wilson J, Douglass J, Botti M, Chapman R, Wulfsohn V, Santamaria N

Poster 3 THE ROLE OF HEALTH AND ECONOMIC OUTCOMES IN THE DECISION-MAKING PROCESS AT PUBLIC HOSPITAL : A EUROPEAN SURVEYArnould B, Haslé-Pham E, Späth H-M, Marquis P, Duru G

Poster 4 SPATIAL ANALYSIS ON SUPPLY AND DEMAND FOR MATERNITY HOSPITAL. THE CASE OF RHÔNE-ALPESAuray J-P, Duru G, Mellier G, Papiernik E

Poster 5 RESPONSES TO STANDARD GAMBLES: ARE PREFERENCES 'WELL-CONSTRUCTED'?Baker R, Robinson A

Poster 6 ROUTINE VARICELLA VACCINATION OF CHILDREN IS EFFECTIVE AND COST-BENEFICIAL IN GERMANYBanz K, Neiss A, Goertz A, Klose T, Wutzler P

Poster 7 VALIDATING HEALTH ECONOMIC MODELS: THE EXAMPLE OF EVITAKlose T, Wagenpfeil S, Goertz A, Wutzler P, Banz K

Poster 8 THE USE OF HTA EVIDENCE IN DECISION MAKING: AN EUROPEAN PERSPECTIVEBarbieri M, Drummond M

Poster 9 ECONOMIC IMPACT OF THE 1999-2000 FLU EPIDEMIC ON HEALTH CARE CONSUMPTION IN THE LANGUEDOC-ROUSSILLON REGION - HEALTH INSURANCEPERSPECTIVEBergé C, Passouant M-C, Le Pape A, Fromentin R, El Hasnaoui A, Daures J-P

Poster 10 THE IMPACT OF WAITING TIME TO THE FINAL OUTCOMES AND COSTS IN HIP AND KNEE REPLACEMENTSBlom-Lange M, Sintonen H, Hujanen T, Linna M

Poster 11 ECONOMIC EVALUATION OF NEWBORN HEARING SCREENING – MODELLING OF COSTS AND OUTCOMEHessel F, Grill E, Schnell-Inderst P, Kunze S, Nikisch A, von Voß H, Wasem J

Poster 12 MODELING THE IMPACT OF A NEW ORAL ANTI-DIABETIC (OAD) TREATMENT ON DIABETES COMPLICATION COSTS IN FRANCEBrun-Strang C, Caro J, Annemans L, O’Brien J

Poster 13 IRRITABLE BOWEL SYNDROME (IBS) SIGNIFICANTLY AFFECTS PATIENT QUALITY OF LIFE (QOL) AND IS RESPONSIBLE FOR HIGH COSTS IN FRANCE : THE ENCOLISTUDYBrun-Strang C, Dapoigny M, Wainsten J-P, Lafuma A, Fagnani F

Poster 14 HEALTH CARE EXPENDITURES ANALYSIS: THE APPROACH OF THE FRENCH HEALTH INSURANCE NATIONAL FUNDBrière J, Caillol H

Poster 15 ARE THERE CHARACTERISTICS FOR PRESCRIBING GENERIC DRUGS IN THE GENERAL PRACTITIONERS ?Moneuse P, Cash R, Le Jeunne P, Spira R, Rollot O

Poster 16 DIRECT COST OF LONG TERM PARENTERAL NUTRITION (PN) PATIENTS HOSPITALISED IN THE LARIBOISIÈRE HOSPITAL PN UNIT COMPARISON WITH THE NATIONALCOST SCALE (NCS)Chevalier D, Rusch E, Vahedi K, Bertrand D

Poster 17 THE IMPACT OF ALCOHOL ABUSE ON EMPLOYMENT IN SWITZERLANDChevrou-Séverac H, Jeanrenaud C

Poster 18 PHARMACO-ECONOMIC ASSESSMENT OF THE USE OF RAPID DIAGNOSTIC TESTS IN ADUL PHARYNGITIS IN FRANCEChicoye A,Portier H,Pribil C, Omnes L-F, Boucot I

Poster 19 THE ECONOMIC BENEFITS FOR THE ITALIAN NATIONAL HEALTH SERVICE OF REIMBURSING INTERVENTIONAL RADIOLOGY PROCEDURES ACCORDING TOSPECIFIC DRG’SCiarrapico A-M, Gandini R, Russolillo L

Poster 20 THE POLITICAL-ELECTORAL CYCLE FOR HEALTH CARE IN ITALYCitoni G

Poster 21 THE MEDICO-LEGAL AUTOPSY: A REAL COST ASSESSMENTDelande G, Clément V, Cozic M, Frechin E

Poster 22 ECONOMIC EVALUATION OF FOLLOW-UP OF ALCOHOL DEPENDENT PATIENTS HOSPITALISED UNDERGO WITHDRAWALCombescure C, Nalpas B, Pierre B, Ledent P, Danel T, Playoust D, Jillet C, Martin S, Bozonnat M-C, Balmes J-L, Daurès J-P

Poster 23 LONG TERM MODELLING OF THE COST-EFFECTIVENESS RATIO OF FOLLOW-UP OF PATIENTS WITH COLORECTAL CANCER RESECTED FOR CURECombescure C, Borie F, Millat B, Trétarre B, Daures J-P

Poster 24 EPILEPSY SURGERY AND QUALITY OF LIFECozic M, Crespel A, Picot M-C

Poster 25 TOWARDS A RIGHT TO HEALTH FOR ALLCrémillieux Y

Poster 26 A MARKOV MODEL TO ANALYZING HEART TRANSPLANTATION COSTSd'Alché-Gautier M-J, Malherbe C, Lepage A, Kayhat A, Maiza D

Poster 27 PRIORITIES IN THE ALLOCATION OF LIFESAVING RESOURCES: PROPOSAL OF AN EXTRA-WELFARIST FRAMEWORKDemolliens A

Poster 28 THE IMPACT OF NUTRITIONAL STATUS ON HOSPITAL COSTS: THE CASE OF HIP FRACTURE FOR THE ELDERLYde Pouvourville G, Zazzo J-F

Poster 29 PATIENTS' ORIENTATION IN END STAGE FAILURE: EXPLANATORY FACTORS ?Delarozière J-C, Bongiovanni I, Devictor B, Berland Y, Robert A, Sambuc R

Poster 30 RANDOMISED OSTEOPATHIC MANIPULATION STUDY (ROMANS) - MEASURING THE EFFICACY AND COST-EFFECTIVENESS OF OSTEOPATHIC TREATMENT INPRIMARY CAREEdwards R-T, Linck P, Williams N, Wilkinson C, Russell I

1 1

CONFERENCE

14.30 – 16.00SESSION II


RT 208 OS6a HEALTH CARE SYSTEMS INTRANSITION – COUNTRIES OFCENTRAL AND EASTERN EUROPE I

Chair:GULACSI L(Budapest University)

USING ECONOMIC EVALUATION IN HEALTH POLICY: OPTIONS FORHEALTH CARE SYSTEMS IN TRANSITIONRutten F, Gulacsi L

TEN YEARS OF HEALTH REFORMS IN THE TRANSITION COUNTRIES OFCENTRAL AND EASTERN EUROPE AND OF THE FORMER SOVIET UNION.LESSONS LEARNED AND OPTIONS FOR THE FUTUREBelli P

PUBLIC HEALTH CARE SYSTEM IN HUNGARY AFTER THE TRANSITION: THEEXPERIENCES AND INCENTIVES OF THE APPLICATION OF DIFFERENTFINANCING METHODSDozsa C, Brandtmüller A

A Pol OS9 RISK ADJUSTMENT IN HEALTHECONOMICS

Chair:VAN DE VEN W(Erasmus University Rotterdam)

RISK ADJUSTMENT AND THE DEFINITION OF ACCEPTABLE COSTSSchokkaert E, Van de Voorde C

THE USE OF DIAGNOSTIC COST GROUPS IN RISK ADJUSTMENT - RESULTSFROM GERMAN DATAWasem J, Gress S, Tolksdorff K, Behrend C

FROM A DEMOGRAPHIC TO A HEALTH-BASED RISK ADJUSTMENT SYSTEMFOR COMPETING SICKNESS FUNDS IN THE NETHERLANDS: PCGS IN 2002;COMPLEMENTED WITH DCGS IN 2003 ?Van Vliet R, Lamers L

A Wei PS16 HEALTH CARE SYSTEMPERFORMANCE

Chair:GRIGNON M(CREDES Paris)

CROSS-COUNTRY HETEROGENEITY IN THE EFFECT OF PHYSICIANAVAILABILITY ON HEALTH OUTCOMES AS AN INDICATOR OF HEALTHSYSTEM PERFORMANCEJamison D, Or Z, Wang L

AN ECONOMIC CONCEPTION OF HEALTH PROMOTIONConnelly L

IS THE FRENCH HEALTH INSURANCE AN EFFICIENT INSTRUMENT FORINTRAGENERATIONAL REDISTRIBUTION?Jusot F

RT209 PS22 HEALTH, HEALTH EXPENDITUREAND ECONOMIC GROWTH

Chair:ULMANN P(CES and CNAM Paris)

CONVERGENCE CLUBS IN CROSS-COUNTRY LIFE EXPECTANCY DYNAMICSMayer D

ECONOMIC GROWTH, LONGEVITY, AND THE EPIDEMIOLOGICAL TRANSITIONMorand O

ON THE INTERNATIONAL STABILITY OF THE HEALTH CARE EXPENDITUREFUNCTIONS : ARE PUBLIC AND PRIVATE FUNCTIONS SIMILAR ?Marcuello C, Clemente J, Montanes A, Pueyo F

Monday 8 July 2002

12

€



PROGRAMME


A Del PS33 WILLINGNESS-TO-PAY I

Chair:LEBRUN T(CRESGE Lille)

THE WILLINGNESS-TO-PAY APPROACH TO THE ECONOMIC EVALUATION OFMEDICAL TREATMENTS: THE CASE OF MEN ERECTILE DYSFUNCTIONLe Pen C, Lilliu H, Priol G

WILLINGNESS-TO-PAY FOR AN EARLIER ALLEVIATION OF INFLUENZASYMPTOMSCarrat F, Bungener M, Le Gales C, Marlene N, Schwarzinger M

INFORMATION AND COMMUNICATION TECHNOLOGIES AND NEEDS OF THEELDERLY : AN ANALYSIS OF THE DEMAND AND THE WILLINGNESS TO PAYFOR AN AMBULATORY FOLLOWING-UP BY VIDEOPHONEFrossard M, Genin N

16.30 – 18.00SESSION III


RT208 OS6b HEALTH CARE SYSTEMS INTRANSITION – COUNTRIES OFCENTRAL AND EASTERNEUROPE II


RAMSEY PRICING: A TOOL TO OVERCOME ECONOMIC DISPARITIES OFMARKETSGeursen R

THE PRICE ELASTICITY OF REPORTED ILLNESS IN RUSSIACashin C

UNOFFICIAL PAYMENTS FOR ACUTE STATE HOSPITAL CARE IN KAZAKHSTAN:A MODEL OF VERTICAL SERVICE DIFFERENTIATION AND PHYSICIAN PRICINGXavier A, Thompson R

A Del OS8 ECONOMIC EVALUATION AT ANINTERNATIONAL LEVEL

Chair:LEIDL R(University of Ulm)

DESIGN CONSIDERATIONS IN MULTINATIONAL ECONOMIC EVALUATIONSDrummond M, Manca A, Pang F, Sculpher M

COSTS AND COST-EFFECTIVENESS IN MULTINATIONAL STUDIESKoopmanschap M

USING MODELS FOR EVALUATION IN DIFFERENT COUNTRY CONTEXTSJönsson B

IMPORT AND EXPORT OF ECONOMIC EVALUATIONS: THE CASE OFCHLAMYDIAL SCREENING PROGRAMSWelte R, Jager J, Leidl R

A Wei PS1 AXIOMATIC FOUNDATIONS OFOUTCOMES MEASUREMENT

Chair:AURAY JP(Université Lyon I)

AXIOMS FOR HEALTH CARE RESOURCE ALLOCATIONØsterdal L-P

LISTENING TO RESPONDENTS: A THINK ALOUD STUDY OF DISCRETE CHOICEEXPERIMENT RESPONSESRyan M, Entwistle V, Reeves C

WELFARE ECONOMIC FOUNDATIONS OF HEALTH STATUS MEASURESHougaard J-L, Keiding H

WHOSE PREFERENCES? – A MATTER OF REFERENCE POINTSHappich M

1 3

CONFERENCE


A Pol PS11 EFFECTS OF SUPPLEMENTARYHEALTH INSURANCE ON HEALTHCARE CONSUMPTION

Chair:ZWEIFEL P(University of Zürich)

ASYMMETRIC INFORMATION IN THE PORTUGUESE HEALTH INSURANCEMARKETBago d'Uva T, Santos Silva J-M-C

MEDICAL CONSUMPTION AND SUPPLEMENTAL INSURANCE - BEYONDMORAL HAZARD AND ADVERSE SELECTIONDurand F

SEPARATING ADVERSE SELECTION AND MORAL HAZARD:AN ECONOMETRIC STUDY OF DEDUCTIBLES AND HEALTH EXPENDITURESON SWISS INSURANCE CLAIMS DATAGeoffard P-Y, Gardiol L, Nicolet C

THE EFFECT OF SUPPLEMENTAL HEALTH INSURANCE ON THE UTILIZATIONOF PHYSICIAN SERVICES IN FRANCEBuchmueller T, Couffinhal A, Grignon M, Perronnin M

RT209 PS21 HEALTH WORKFORCE PLANNING

Chair :de KERVASDOUÉ J(CNAM Paris)

PREDICTING THE FUTURE DEMAND AND SUPPLY OF THE MEDICALWORKFORCE: A SHOT IN THE DARK?Scott A, Elliott R, Mavromaras K

THE MEDICAL DEMOGRAPHICS IN FRANCE BY THE YEAR 2020Breuil-Genier P, Darriné S, Niel X

WILL INCREASED WAGES INCREASE SUPPLY OF NURSES? A PANEL DATAANALYSIS OF NURSES' LABOUR SUPPLYAskildsen J-E, Altagi B, Holmas T-H

Monday 8 July 2002

14

16.30 – 18.00SESSION III

€



PROGRAMME

Tuesday 9 July 2002


RT209 OS4 INTEGRATION/COORDINATION INTHE HEALTH CARE SYSTEM

Chair:GADREAU M(Université de Bourgogne)

PHYSICIANS' NETWORK : ORGANISATION AND COORDINATION ISSUES INFRANCELe Pen C

HUNGARIAN MANAGED CARE PILOT PROGRAM - A VERTICAL INTEGRATIONOF DIFFERENT LEVELS OF PROVISIONSNagy B, Dozsa C, Lepp-Gazdag A

DEVELOPMENT OF HOSPITAL PHARMACEUTIC SERVICES : BETWEEN SEARCHFOR EFFICIENCY AND PRESERVATION OF AUTONOMY OF PROFESSIONALSVinot D, Fraisse S, Reymond J-P, Rigaud-Bully C, Späth H-M

RESTRUCTURING THE FRENCH HEALTH CARE SYSTEM THROUGH REGIONALNETWORKS. THE CASE OF FAQSV (FUND FOR THE IMPROVEMENT OFAMBULATORY CARE)Pelissier F, Gadreau M

RT112 OS16 RISK PERCEPTION ANDPREVENTION

Chair:COUDEVILLE L & DERVAUX B(CRESGE)EECKHOUDT L(University of Mons)

HEALTH RISK: RISK PREMIUM AND PRUDENCEBien F

ELICITING PREFERENCES FOR REDUCTIONS OF SMALL RISKNorinder A

PREVENTION BY VACCINATION : THE ECONOMICS OF IMMUNISATIONPROGRAMMESEdmunds J

A Del PS3 COST STUDIES

Chair:LEVY E(Université Paris IX Dauphine)

DETERMINANTS OF THE COST OF ASTHMA IN ILE-DE-FRANCECom-Ruelle L, Grandfils N, Midy F, Sitta R

COST MEASUREMENT OF HIVAIDS PREVENTION AND TREATMENT: LESSONS FOR OBTAINING RELIABLEESTIMATES AT THE NATIONAL LEVELBeaston-Blaakman A

ECONOMICS OF THE CLINICAL MANAGEMENT OF LUNG CANCER IN FRANCEFROM CENSORED DATACombescure C, Daures J-P, Molinier L, Vergnenegre A

THE WELFARE COST OF ADDICTIONJürges H

A Wei OS2 REGIONAL HEALTH CARE IN AFEDERAL EUROPE

Chair:LOPEZ CASASNOVAS G(University Pompeu Fabra)

A MULTILEVEL ANALYSIS ON THE DETERMINANTS OF REGIONAL HEALTHCARE EXPENDITURESaez M, Lopez Casasnovas G

POSSIBLE IMPLICATIONS OF A FEDERAL EUROPE FOR REGIONAL HEALTHPOLICYMAKING IN ITALYFrance G

REGIONAL HEALTH CARE, TRANSREGIONAL SOLIDARITY, AND THE ROLE OFTHE STATE IN GERMANYJacobs K

9.00 – 10.30SESSION IV

15

CONFERENCE


RT208 PS34 WILLINGNESS-TO-PAY II

Chair:LAUNOIS R(Université Paris Nord)

INFORMATION ON HEALTH RISKS AND WILLINGNESS-TO-PAY FOR FOODPRODUCTS : EXPERIMENTAL ANALYSISStenger A, Rozan A, Willinger M

WILLINGNESS TO PAY FOR A QALYGyrd-Hansen D

WILLINGNESS TO PAY TO AVOID MINOR MORBIDITY: AN INTERNATIONALCOMPARISONYeung R, MC Ghee S, Smith R-D

11.00 – 12.30SESSION V


A Del OS5 PRICING AND PATENTINGREGULATIONS OF DRUGS INEUROPE

Chair:de POUVOURVILLE G(CREGAS – INSERM U537)

PRICING OF DRUGS IN SWEDEN: IMPACT ON INNOVATIONJönsson B

PRICING AND WELFARE IMPLICATIONS OF PARALLEL IMPORTS IN THEPHARMACEUTICAL INDUSTRYJelovac I, Bordoy C

PRICING OF DRUGS IN EUROPE: IS THE RAMSEY PRICE FRAMEWORKADEQUATE?de Pouvourville G, Godet V

DYNAMIC COMPETITION IN PHARMACEUTICALS: ON PATENT EXPIRY,GENERIC PENETRATION, AND INDUSTRY STRUCTURE INPammolli F, Riccaboni M, Magazzini L

A Wei OS11 COST OF AGEING AND COST OFDYING

Chair:ZWEIFEL P(University of Zürich)

DOES AGEING OF POPULATION HAS AN IMPACT ON HEALTH CAREEXPENDITURES? EVIDENCE FROM GERMANYSauerland D

EFFECT OF CONJUGAL BEREAVEMENT ON MORTALITY AND HEALTHSTATUS AT OLDER AGESPortrait F, Lindeboom M, van den Berg G

THE IMPACT OF AGE AND PROXIMITY TO DEATH ON HEALTH CAREEXPENDITURESSeshamani M, Gray A

A Pol PS23 HOSPITAL FINANCING

Chair:JÖNSSON B(Stockholm School of Economics)

CONTRACTS AND HOSPITAL FINANCING IN A MORAL HAZARDENVIRONMENTGomes J-P

PROSPECTIVE PAYMENT SYSTEMS AND HOSPITAL HETEROGENEITYDormont B, Milcent C

THE EFFECT OF ACTIVITY BASED FINANCING ON HOSPITAL EFFICIENCY:PANEL DATA ANALYSES 1992-2000Hagen T, Biorn E, Iversen T, Magnussen J

Tuesday 9 July 2002

16

€



PROGRAMME


A Pol PS2 COMPETITION AND REGULATIONOF HEALTH CARE

Chair:POLTON D(CREDES)

ARE DIFFERENTIAL CO-PAYMENT RATES APPROPRIATE IN THE HEALTHSECTOR?Eeckhoudt L, Marchand M, Pestieau P, Piaser G

SIGNALLING AND REPUTATION FORMATION IN A PERFECTLY COMPETITIVEHEALTH CARE MARKETSilva S

QUALITY IN THE PROVISION OF HEALTH SERVICES. MARKET EQUILIBRIUMAND PUBLIC REGULATIONBelli P

PRIVATE PROVISION OF PUBLICLY FUNDED HEALTH CARE ? INCENTIVES,CONSTRAINTS, IMPACTSussex J, Goddard M

RT208 PS25 METHODOLOGY OF PREFERENCEELICITATION

Chair:BUXTON M(Brunel University)

A TEST OF THE PREDICTIVE VALIDITY OF QALYS USING CHRONIC ANDTEMPORARY TIME TRADEOFF VALUESPinto-Prades J-L, Abellan-Perpinan J-M, Badia-Llach X, Mendez I

CHAINED TIME TRADE-OFF AND STANDARD GAMBLE METHODS:APPLICATIONS IN OESOPHAGEAL CANCERMcNamee P

COMPARISON OF OPEN-ENDED AND DISCRETE CHOICE METHODS OFESTIMATING TIME PREFERENCE FOR FUTURE HEALTH STATESCairns J

MODELING RISKY CHOICES WHEN THE PROBABILITIES OF OUTCOMES AREVERY LOW AND VERY HIGH : CHOICES REGARDING PRENATAL DIAGNOSIS OFDOWN SYNDROMEGautier L, Seror V, Fericelli A-M

RT209 PS30 REGIONAL HEALTH CARE

Chair:FRANCE G(Consiglio Nazion. delle Ricerche)

DEVELOPING THE FORMULA FOR STATE SUBSIDIES FOR HEALTH CARE INFINLANDHakkinen U, Jarvelin J-A

IMPROVING GEOGRAPHIC EQUITY: A LOCATION-ALLOCATION MODEL TOREDISTRIBUTE HOSPITAL SUPPLYOliveira M

THE REFORM OF THE ROMANIAN HEALTH CARE SYSTEM. A STUDY OFREGIONAL HEALTH DIRECTORATES DURING 1990’SAndren D

RT112 OS12 TAXATION AND ADDICTION

Chair:LOPEZ NICOLAS A(University Pompeu Fabra)

THE EFFECT OF TOBACCO TAXES ON SMOKING IN A RATIONAL ADDICTIONMODEL USING SPANISH PANEL DATALabeaga J-M, Badénes-Pla N

DO TOBACCO TAXES INFLUENCE STARTING AND QUITTING SMOKING?EVIDENCE FROM A SAMPLE OF IRISH WOMENMadden D

TOBACCO CONTROL POLICIES AND SMOKING CESSATION : A CROSSCOUNTRY ANALYSISKenkel D, Lillard D, Mathios A

1 7

CONFERENCE

13.30 – 14.30POS II: POSTER SESSION IIRoom: CHA


Poster 31 EVALUATION OF ASTHMA MANAGEMENT COST BY SEVERITY STAGEEl Hasnaoui A, Godard P, Launois R, Richard A, Neukirch F

Poster 32 THE INFLUENCE OF SOME CHARACTERISTICS OF THE GENERAL PRACTITIONER (GP) FOR THE DECISION TO HAVE OR TO USE A SPECIFIC LABORATORY ANALYSISFauli S, Thue G, Sandberg S

Poster 33 HOME CARE AND HOME SERVICES QUALITY FOR ELDERLY DEPENDENT PEOPLE : HOW TO ASSESS QUALITY ?Fermon B

Poster 34 THE FRENCH VERSION OF THE PSORIASIS DISABILITY INDEXFinlay A, Dreno B, Corvest M, Myon E, Taieb Ch

Poster 35 ANALYSIS OF HOSPITAL READMISSIONS IN TUSCANY: FREQUENCY, ECONOMIC VALUE, AND DETERMINANTSForni S, Tediosi F, Cislaghi C

Poster 36 TREATMENT PATTERNS AND COSTS ASSOCIATED WITH VENOUS THROMBOEMBOLISM (VTE). A MULTI-COUNTRY STUDYde Groote K, Gabriel S, Minjoulat-Rey M-C, Lamotte M, Annemans L

Poster 37 PRELIMINARY FINDINGS OF THE EVALUATION OF THE FIRST NATIONAL UK BASED CANCER GENETICS SERVICEGriffith G, Edwards R-T, Gray J

Poster 38 PREFERENCES FOR CANCER GENETICS SERVICES PRIOR TO COUNSELLING: PRELIMINARY FINDINGSGriffith G, Edwards R-T, Williams M, Gray J

Poster 39 PATIENTS’ CHOICE AND QUALITY OF CARE IN TEACHING HOSPITALSGuccio C, Pignataro G

Poster 40 ECONOMIC EVALUATION OF AN EDUCATION PROGRAM FOR PATIENTS WITH COPDHessel F, Wittmann M, Spohn S, Petro W, Wasem J

Poster 41 ECONOMIC EVALUATION OF THE ARTIFICIAL LIVER SUPPORT SYSTEM MARS: COSTS, SURVIVAL AND QUALITY OF LIFEHessel F, Mitzner S-R, Rief J, Wasem J, Guellstorff B

Poster 42 COST OF TREATMENT AND FOLLOW-UP OF BREAST CANCER : A RETROSPECTIVE EVALUATION IN A COMPREHENSIVE CANCER CENTRE (CLCC)Brun-Strang C, Lilliu H, Berlie J, Rouesse J

Poster 43 MEDICAL FOLLOW-UP IN A FREE ACCESS TO PRACTITIONERS HEALTH CARE SYSTEM: THE MARFAN SYNDROME EXAMPLE IN FRANCEHirtzlin I, Kieyila-Loubaki F, Jondeau G

Poster 44 COST-BENEFIT APPROACH FOR EVALUATING INVESTMENT INTO ORGAN DONATIONKalo Z, Roels L, Boesebeck D, Whiting J-F, Kiberg B

Poster 45 A PUBLIC-USE MODEL FOR COST-EFFECTIVENESS ANALYSIS OF PRESCHOOL VISION SCREENING: APPLICATION TO A PROGRAM IN GERMAN KINDERGARTENSKönig H-H, Barry J-C

Poster 46 PREVALENCE AND DESCRIPTION OF CHRONIC DAILY HEADHACHE IN THE GENERAL POPULATION IN FRANCELantéri-Minet M, Auray J-P, Gaudin A-F

Poster 47 COST-EFFECTIVENESS ANALYSIS OF ORAL VINORELBINE IN THE TREATMENT OF NON SMALL CELL LUNG CANCERLe Lay K, Megnigbeto A-C, Launois R

Poster 48 CREATION OF AN AP-HP AND CRLCC INTRANET DATABASE IN THE CONTEXT OF THE 2000 PROGRAMME TO SUPPORT EXPENSIVE NEW DIAGNOSTIC ANDTHERAPEUTIC DEVELOPMENTSLe Lay K, Lotz J-P, Megnigbeto A-C, Launois R

Poster 49 SMOOTHED BOOTSTRAP TO ESTIMATE CONFIDENCE INTERVAL FOR COST-EFFECTIVENESS RATIOSLenne X

Poster 50 THE REFINEMENT OF THE CAPITATION FORMULA IN HUNGARIAN MANAGED CARE PILOT PROGRAMLepp-Gazdag A, Nagy B, Dózsa C

Poster 51 PRICING OF BRAND-NAME DRUGS AND PRODUCT SELECTIONLu H, Mallory C

Poster 52 PROXIMITY OF CARE OR CONCENTRATION ?Lucas-Gabrielli V, Tonnellier F

Poster 53 MEASURING THE VALUE OF LOST LEISURE TIME IN COST-EFFECTIVENESS STUDIESMaljanen T

Poster 54 THE SOCIO-ECONOMIC COST OF DYSKINESIA ASSOCIATED WITH L-DOPA TREATMENT IN PATIENTS PRESENTING WITH PARKINSON’S DISEASEMaurel F, Regnauld M-H, Lilliu H, Le Pen C

Poster 55 A COST-EFFECTIVENESS MODELLING OF A NON SPECIFIC IMMUNOSTIMULATING PREVENTIVE TREATMENT (OM-85 BV) FOR RECURRENT UPPER RESPIRATORYTRACTS INFECTIONS IN CHILDREN IN FRANCEMegas F, Baron F, Boulanger P, Cozma G

Poster 56 FIVE YEAR FOLLOW UP OF CEREBROVASCULAR ACCIDENTS DEPENDING ON THE LEVEL OF INDEPENDENCE AND CARE MANAGEMENT STRUCTURESMegnigbeto A-C, Launois R, Giroud M, Durand I, Gaudin A-F

Poster 57 CLINICAL VALIDATION OF A SCALE FOR VERTIGO: EEV (EUROPEAN EVALUATION OF VERTIGO)Megnigbeto A-C, Sauvage J-P, Claveau A, Launois R

Poster 58 HEALTH STATUS AND HEALTH INSURANCE CHOICE: AN EMPIRICAL MODEL FOR GERMANYKnaus T, Nuscheler R

Poster 59 MEDICAL PRACTICE VARIABILITY AMONG GENERAL PRACTITIONERS: THE CASE OF HYPERLIPIDEMIAMousquès J, Renaud T, Sermet C

Poster 60 A LONGITUDINAL STUDY OF MORBIDITY AND HEALTH CARE CONSUMPTIONNaudin F, Auvray L

Poster 83 CHANGE MANAGEMENT AND PROFESSIONAL INTEGRATION IN PRIMARY CARE: ANALYSIS OF CASE STUDIES AND TRENDS IN ITALY’S NATIONAL HEALTH SYSTEMTedeschi P, Vendramini E

Tuesday 9 July 2002

18

€



PROGRAMME

14.30 – 16.00SESSION VI


RT208 OS7 BAYESIAN APPROACH

Chair:O'HAGAN A(University of Sheffield) &ABRAMS K(University of Leicester)

IDENTIFYING FOR WHICH PATIENTS AN INTERVENTION IS COST-EFFECTIVE: ABAYESIAN APPROACH TO SUBGROUP ANALYSESAbrams K, Cooper N-J, Sutton A-J, Lambert P-C

BAYESIAN SENSITIVITY ANALYSIS OF ECONOMIC MODELSO'Hagan A, Oakley J

BAYESIAN LEARNING IN INNOVATION DIFFUSION MODEL AND BAYESIANMETHODS OF ESTIMATION : THE CASE OF MEASLES VACCINECoudeville L

A Wei OS10 MICROECONOMIC APPROACHESFOR UNDERSTANDING THEPHYSICIAN-PATIENT ENCOUNTER

Chair:CARRERE M-O(CNRS – UMR5823 – Univ. LYON I)

THE PHYSICIAN-PATIENT ENCOUNTER - AN ECONOMICS PERSPECTIVEGafni A

THE SEARCH FOR A SECOND OPINION INITIATED BY THE PATIENT - WHATDOES IT MEAN AFTER THE IMPLEMENTATION OF PRACTICE GUIDELINES?Moumjid N, Gafni A, Carrere M-O

THE PHYSICIAN-PATIENT RELATIONSHIP AS A GAME OF STRATEGICINFORMATION TRANSMISSIONDe Jaegher K

A Pol OS13 FREE CHOICE OF SICKNESSFUNDS IN REGULATEDCOMPETITION - EVIDENCE FROMTHE NETHERLANDS, GERMANYAND SWITZERLAND

Chair:GRESS S(University of Greifswald)

SWITCHING BEHAVIOR OF CONSUMERS IN DUTCH SOCIAL HEALTHINSURANCELaske Aldershof T, Schut E

TOWARDS MORE CHOICE IN SOCIAL PROTECTION? INDIVIDUAL CHOICE OFINSURER IN BASIC MANDATORY HEALTH INSURANCE IN SWITZERLANDColombo F

FREE CHOICE OF SICKNESS FUNDS IN SOCIAL HEALTH INSURANCE -THEORETICAL FOUNDATION AND EMPIRCAL FINDINGS IN GERMANYGress S, Wasem J, Schut E

A Del PS6 DRUGS AND REGULATION

Chair:GOUVEIA PINTO C(Universidade nova de lisboa)

EFFECT OF PHARMACEUTICAL REGULATION ON THE LAUNCH OF NEW DRUGSWang R, Danzon P, Wang L

SHOULD WE DELEGATE THE TASK OF SANITARY SUPERVISION TOINDEPENDENT REGULATORY AGENCIES ? AN APPLICATION TO THE CASE OFDRUG APPROVAL PROCESSMalguid C

IMPACT OF THE INFRINGEMENT LAWSUIT ANNOUNCEMENTS ON THE FIRMSQUOTED VALUE AND THEIR TRADE PARTNERS : AN EMPIRICAL ANALYSIS TOTHE PHARMACEUTICAL AND BIOTECHNOLOGICAL SECTORBen Lakhdar C

19

CONFERENCE

16.30 – 18.00SESSION VII


A Wei OS15 EFFECT OF OWNERSHIP ANDMANAGEMENT ON PROVIDERS'-PERFORMANCE

Chair:IVERSEN T(University of Oslo)

MEASURING HOSPITAL PERFORMANCEPita Barros P

COMPETITION AMONG PRIVATE HEALTH PROVIDERS UNDER ADVERSESELECTIONOlivella P, Vera-Hernandez M

FINANCING SPECIALIST SERVICES IN THE NETHERLANDS: WELFAREIMPLICATIONS OF IMPERFECT AGENCYWesterhout E, Folmer K

A Del PS7 DRUGS MARKET : STRUCTURE,PRICING AND ADVERTISING

Chair:BUXTON M(Brunel University)

THE EFFECT OF DIRECT-TO-CONSUMER ADVERTISING INPHARMACEUTICAL MARKETSBrekke K, Kuhn M

DIRECT-TO-CONSUMER ADVERTISING OF PRESCRIPTION DRUGS: A COMPA-RATIVE STUDY OF PATIENT REQUESTS FOR MEDICINES IN PRIMARY CAREMintzes B, Barer M, Kravitz R, Kazanjian A, Bassett K, Lexchin J, Evans R,Pan R, Marion S

MARKET STRUCTURE AND INFECTIOUS DISEASESMechoulan S

MONOPOLY PRICING IN THE MARKET FOR VACCINESNuscheler R, Kessing S


RT112 PS18 HEALTH IN CENTRAL ANDEASTERN EUROPE COUNTRIES


DOES SELF-ASSESSED HEALTH STATUS CONTRIBUTE TO LIFE SATISFACTIONIN ROMANIA?Andren D

SELF-ASSESSED HEALTH AND INCOME IN RUSSIA: 1994-2000Stepanyan A

THE DEMAND FOR HEALTH SERVICES IN THE UKRAINE AND IN THEKARELIAN REPUBLIC, RUSSIAValtonen H, Noro A, Seppo S

RT209 PS27 PERFORMANCE MEASUREMENTOF ORGANISATION I

Chair:MOSSÉ P(CNRS – Université Aix-Marseille)

ASSESSING FRENCH NURSING HOME EFFICIENCY: AN INDIRECT OUTPUTDISTANCE APPROACHDervaux B, Leleu H, Nogues H

DEMONSTRATING ECONOMIES OF SCOPE IN MATERNITY SERVICES: ANEMPIRICAL ANALYSIS IN FRENCH PUBLIC HOSPITALSLe Vaillant M, Combier E, de Pouvourville G

THE EFFICIENCY AND QUALITY OF THE INSTITUTIONAL LONG TERM CAREFOR THE ELDERLYLaine J, Linna M, Hakkinen U, Noro A

Tuesday 9 July 2002

20

€



PROGRAMME


RT209 PS15 HEALTH CARE ORGANISATIONAND COORDINATION

Chair:GADREAU M(Université de Bourgogne)

ASSESSMENT OF THE GLOBAL COST OF HOME HEALTH CARECom-Ruelle L, Aligon A, Lebrun E, Raffy-Pihan N

THE EMERGENCE OF PATIENT TRAJECTORIES AS A NEW OBJECT TO GOVERNHEALTH POLICIES - CASE STUDIES OF PATIENT MANAGEMENT IN DIALYSISAND CARDIOLOGYLenay O, Engel F, Moisdon J-C

THE ANALYSIS OF A CARDIOSURGICAL NETWORK IN A REGULATED SETTING:A BAYESIAN APPROACHLippi Bruni M, Nobilio L, Ugolini C

THE RIGHT EVALUATION FOR THE RIGHT NETWORKSButtard A

A DISEASE MANAGEMENT PROGRAM IN FRANCE: LESSONS FROM THERESALIS EXPERIMENT BEFORE AND AFTER PUBLIC HEALTH INTERVENTIONSLaunois R, Megnigbeto A-C, Perez V, Roy M, Duroux P, Camus A, GailhardouM, Lançon F, Quéniart M

A Pol PS24 METHODOLOGY OF ECONOMICEVALUATION

Chair:DRUMMOND M(University of York)

WHICH CALCULATION METHODS OF THE INCREMENTAL COST-EFFECTIVENESSRATIO CONFIDENCE REGIONS TO CHOOSE?Siani C, Le Corroller A-G

TESTING FOR SCOPE EFFECTS IN HEALTH CARE USING THE CONTINGENTVALUATION METHODLazaro A, Ryan M, San Miguel F

UNCERTAINTY AND ECONOMIC EVALUATION WITH CONSTRAINEDRESOURCES AND A PORTFOLIO OF HEALTH CARE PROGRAMMESGafni A, Birch S, Maiwenn J, Sendi P

RT112 PS28 PERFORMANCE MEASUREMENTOF ORGANISATION II:DEA METHOD

Chair:DERVAUX B(CRESGE – Lille)

COMPARATIVE EFFICIENCY OF TERTIARY CARE HOSPITALS IN UKRAINEPilyavsky A, Aaronson W, Golubchikov M

ECONOMIES OF SCOPE IN NORWEGIAN HOSPITAL PRODUCTION -A DEA ANALYSISMagnussen J, Kittelsen S

MEASURING AND EVALUATING THE EFFICIENCY OF NHS TRUSTS INENGLAND: A NON-PARAMETRIC AND ECONOMETRIC ANALYSISSilva S

RT208 PS31 RISK ADJUSTMENT FOR HEALTHCARE FINANCING

Chair:MAYNARD A(University of York)

COMPARING THE FINANCIAL RISK OF DRG BASED AND BED-DAY PRICINGUSING PARAMETRIC AND SIMULATION METHODSMikkola H, Sund R, Linna M, Hakkinen U

MARKET STRUCTURE AND COMPOSITION IN THE SUPPLY OF HOSPITALSERVICESPignataro G, Rizzo I

THE RISK ADJUSTED VISION BEYOND CASEMIX (DRG) FUNDING INAUSTRALIA: EUROPEAN LESSONS IN CAPITATION AND HIGH COMPLEXITYAntioch K, Walsh M

21

CONFERENCE

Wednesday 10 July 2002

9.00 – 10.30SESSION VIII


A Pol OS3 THE EFFICIENT PRODUCTION OFHEALTH CARE IN EUROPE

Chair:HOLLINGSWORTH B(Monash University) &PARKIN D(City University)

THE EFFICIENT PRODUCTION OF HEALTH CARE AND EDUCATION IN UKHOSPITALSHollingsworth B, Parkin D

COMPARING HOSPITAL EFFICIENCY IN THE NORDIC COUNTRIES: THE CASEOF NORWAY & FINLANDLinna M, Häkkinen U, Magnussen J

WAITING LISTS, EFFICIENCY AND CAPACITY UTILISATION: AN APPLICATIONTO SPANISH HOSPITALSPriori D, Sola M

A Bin PS4 DECISION MAKING, EQUITY ANDPRIORITY SETTING IN HEALTHCARE

Chair:MAJNONI D'INTIGNANO B(Université Paris XII)

FAIR EQUALITY OF OPPORTUNITY AND THE RIGHT TO HEALTHCARENunes R, Nunes C, Rego G

PRICE CONTROL AND REGULATION OF RESEARCH IN HEALTH: EMERGENCEOF NEW PUBLIC DECISION CRITERIAForay D, Bartoli F

THE 'BERMUDA TRIANGLE' OF HEALTH CARE EVALUATION:COST-EFFECTIVENESS, EQUITY AND PATIENT PREFERENCESDowie J

WHICH IS THE JUST DISTRIBUTION OF HEALTH CARE? A CROSS-COUNTRYCOMPARISON ON PEOPLE’S VIEW IN FRANCE AND SWEDENBoarini R, Martinsson P

A Del PS10 ECONOMIC EVALUATION STUDY II

Chair:RUTTEN F(Erasmus University Rotterdam)

ADJUNCTION OF POLYMERASE CHAIN REACTION IN SCREENING FORHEPATITIS C VIRUS RNA IN BLOOD DONATIONS: MISUSE OF THEPRINCIPLE OF CAUTIONLoubiere S, Costagliola D, Durand-Zaleski I, Rotily M

COST EFFECTIVENESS ANALYSIS OF DROTRECOGIN ALFA (ACTIVATED) AS ATREATMENT FOR SEVERE SEPSIS IN HOSPITALISED PATIENTSLaunois R, Riou-Franca L, Aegerter P, Guidet B,Huet X, Meshaka P, Pinton M

ECONOMIC EVALUATION OF CANCER GENETICS COUNSELLING AND TESTINGEdwards R, Gray J, Griffith G, Turner J, Wilkinson C, France B, Brain K,Bennet P

POST-EXPOSURE PROPHYLAXIS AFTER NON-OCCUPATIONAL HIV EXPOSURE:A COST-EFFECTIVENESS ANALYSIS IN THE FRENCH CASECoudeville L, Bercez C, Sailly J-C

22

€



PROGRAMME


RT208 PS17 HEALTH DETERMINANTS

Chair:SAILLY J-C(CRESGE - Lille)

HEALTH CARE AND HEALTH OUTCOMES IN INDUSTRIALISED COUNTRIES:ANY CONNECTION?Or Z

MEASURING CHANGES IN INFANT MORTALITY RATES IN OECD COUNTRIESValdmanis V, Margaritis D

PREDICTORS OF ELDERLY MORTALITY: HEALTH PROXIES, SOCIALDETERMINANTS OF HEALTH AND SOCIOECONOMIC CHARACTERISTICSMete C

A Wei PS20 HEALTH PROFESSIONALS ANDINCENTIVES

Chair:LANCRY P-J(CNAMTS Paris)

ADOPTION OF NEW TECHNOLOGIES: INCENTIVES FOR PHYSICIANSKühn A

INCENTIVE CONTRACTS AND THE COMPENSATION OF HEALTH CAREPROVIDERSAllard M, Cremer H, Marchand M

RISK SHARING BETWEEN SICKNESS FUNDS AND PRIMARY CARE PHYSICIANSAaldijk M, Van Vliet R

THE EFFECT OF PAYER-PROVIDER NEGOTIATIONS ON PAYMENT SYSTEM ANDPROVISION OF HEALTH CAREBrekke K, Askildsen J-E, Straum O-R

RT209 PS32 TREATMENT CHOICE ANDPROVIDER INCENTIVES

Chair:ROCHAIX-RANSON L(Université Aix-Marseille II)

INFORMATION ASYMMETRY, INSURANCE AND THE DECISION TOHOSPITALIZELeger P-T, Blomqvist A

OVERCOMING THE BARRIERS TO TREATING ILLICIT DRUG USERS IN PRIMARYCAREBate A, Bond C, Pitcairn J, Ryan M

TREATMENT CHOICE AND HOSPITAL REIMBURSEMENTLesur R

TREATMENT STRATEGIES, DOCTORS' ERRORS AND PATIENTS' BENEFITS INCOMPETITIVE PRIMARY CAREMasiero G

Room

A BinCLOSINGPLENARYSESSION

Session

PLS3

PLS4

Keynote speakers

ENTHOVEN A (Stanford University):American Health Care in the 1990s: Some Lessons for Europeans

JÖNSSON B (Stockholm School of Economics):Evaluation and Policy making

11.00 – 12.30

23

13.30 – 14.30POS III: POSTER SESSION IIIRoom: CHA


Poster 61 INSURANCE CLAIMS AS A DEVICE FOR MEASURING THE PHARMACISTS SUBSTITUTION RIGHT IN A FRENCH DEPARTMENTMegnigbeto A-C, Le Lay K, Launois R

Poster 62 EUROPEAN DISCREPANCIES IN PRICES, EXPENDITURE AND UTILISATION OF ANTIMIGRAINE MEDICINESPalazzo F, Folino-Gallo P, Martelletti P, Mennini F

Poster 63 COST-EFFECTIVENESS OF HEPATITIS A VACCINE IN PREVENTION OF SECONDARY HEPATITIS A INFECTIONPechevis M, Lafuma A, Khoshnood B, Durand I

Poster 64 INTANGIBLE COSTS OF ALCOHOL DEPENDENCY AS A PUBLIC GOOD: AN ESTIMATE FOR SWITZERLAND BASED ON CONTINGENT VALUATION SURVEYPellegrini S, Jeanrenaud C

Poster 65 RELEVANCE OF MICROECONOMIC REGULATION OF ACTIVITY FOR FRENCH GPSPereira C

Poster 66 THE CONCEPT OF PATIENTS’ TRAJECTORIES AS A USEFUL TOOL TO IMPROVE THE DECISION MAKING BASED ON THE PMSI DATA IN THE FRENCH HEALTH SYSTEMPerrier L, Philip T, Baron P-S

Poster 67 IMPACT OF UNIVERSAL HEALTH INSURANCE (COUVERTURE MALADIE UNIVERSELLE) ON ACCESS TO AND CONSUMPTION OF HEALTH CARES : AN EVIDENCEOF THRESHOLD EFFECT COMING FROM SOCIAL SCHEDULES ?Paraponaris A, Moatti J-P, Perrin V, Obadia Y

Poster 68 GENERAL PRACTITIONERS : STANDARDS OF PRACTICE, THE CASE OF SICKNESS BENEFIT NOTESPigeon P

Poster 69 CONCEPT ON REFORM OF HEALTH CARE FINANCING IN RUSSIA: COMPLEX APPROACH AND PRIORITIESPleshanov A, Simpson D

Poster 70 THE CONSTRUCTION OF MULTIDISCIPLINARY MODEL OF EFFECTIVENESS AND EFFICACY OF THE SURGICAL TREATMENT OF EPILEPSY IN FINLANDPutkonen P, Granström M-L, Ylinen A, Katila T, Sintonen H

Poster 71 MIGRAINE IN FRANCE IN 2000 – SOCIO-ECONOMIC IMPACTPradalier A, Auray J-P, Gaudin A-F

Poster 72 COMPETING MODELS OF HOSPITAL ADMINISTRATION. THE PORTUGUESE EXPERIENCERego G, Nunes R

Poster 73 CANCER-RELATED PUBLIC EXPENSES: COMPARED COSTS OF HOME-CARE AND HOSPITALRemonnay R, Morelle M, Devaux Y, Carrere M-O

Poster 74 IS THERE ATHIRD WAY IN HEALTH CARE? " A COMPARISON OF QUALITY MANAGEMENT INITIATIVES IN GERMANY AND THE UNITED KINGDOM "Riemer-Hommel P, Allen P

Poster 75 REGIONAL IMPRINT ON CONTROL AND EVALUATION SYSTEMS IN ITALIAN PUBLIC HOSPITALS. THE EXPERIENCE OF THE VENETO REGIONRusso S

Poster 76 ASSESSMENT OF THE COST OF COLORECTAL CANCER (CRC) IN FRANCESelke B, Durand I, Marissal J-P, Lebrun T

Poster 77 PALLIATIVE CARE IN LUNG CANCER. A PROSPECTIVE EXPERIENCE IN NURSING APPROACH AND TIME EVALUATIONBousquet P-J, Sene E, Coste E, Del Bucchia F, Vincent D, Daures J-P

Poster 78 WHAT IS THE BEST IMAGING STRATEGY FOR STROKE? AN ECONOMIC EVALUATION OF CT SCANNING STROKE PATIENTSSeymour J, Cairms J, Wardlaw J, Sandercock P, Keir S

Poster 79 LOSARTAN REDUCES THE COSTS ASSOCIATED WITH ESRD IN DIABETIC TYPE 2 PATIENTS: RENAAL STUDY ECONOMIC EVALUATION ADAPTED TO FRANCEHannedouche T, Rodier M, Carides G-W, Souchet T, Passa P

Poster 80 THE USE OF ECONOMIC INFORMATION IN HOSPITAL FORMULARY DECISION-MAKING IN THE FRENCH RHÔNE-ALPES REGIONSpäth H-M, Charavel M, Morelle M, Remonnay R, Carrère M-O

Poster 81 PHARMACEUTICAL MARKET OF BORDEAUX UNIVERSITY HOSPITAL : DEMONSTRATION OF A SPECIFICITYTaboulet F, Dulin R, Bonnin M, Saux M-C

Poster 82 SUPPLIED GENERIC MEDICINES : ANALYSIS OF THE SUPPLYTaboulet F, Haramburu F, Latry F

Poster 84 THE REGIONALISATION OF HEALTH CARE IN ITALY: A COMPARISON OF TWO REGIONAL HEALTH SERVICESTediosi F, Cislaghi C, Forni S

Poster 85 PORTUGAL’S PUBLIC HOSPITAL FINANCING MODEL: A GLOBAL PERSPECTIVETranquada S, Henriques M, Moura A, Batista P

Poster 86 MEDICOECONOMIC ASSESSMENT OF TREATMENT OF RECURRENT ACUTE RHINOPHARYNGITIS IN 18-MONTH-OLD TO 4-YEAR-OLD CHILDREN BY GENERALPRACTITIONERSVainchtock A, Lamarsalle L, Chaufferin G, Dansette G-Y, Duru G

Poster 87 THE COST OF DRUGS TREATMENT FOR DIABETES MELLITUSValpiani G, Degli Esposti L, Saragoni S, Degli Esposti E

Poster 88 RISK ADJUSTMENT METHODOLOGIES FOR ESRD PATIENTS UNDER HAEMODIALYSIS THERAPYVieira M

Poster 89 ESOMEPRAZOLE IS COST-EFFECTIVE COMPARED WITH "CLINICAL PRACTICE" IN THE ACUTE AND LONG-TERM TREATMENT OF PATIENTS WITH GORDWITHOUT OESOPHAGITIS IN THE UKWahlqvist P, Higgins A, Hedbrant J, Green J

Poster 90 EVALUATING THE IMPACT OF INTRODUCING NEW DIAGNOSTIC OR THERAPEUTIC PROCEDURES: A TOOL FOR HELPING RESEARCHERS AND HOSPITALSWasserfallen J-B, Bona F, Hude D


24

CONFERENCE

€

14.30 – 16.00SESSION IX


A Wei OS1 PAYMENT TO DOCTORS INAMBULATORY CARE

Chair:ROCHAIX-RANSON L(Université Aix-Marseille II)

ALTERNATIVE SYSTEMS FOR FINANCING HEALTH CARE AND PAYINGPHYSICIAN SERVICESLevaggi R, Rochaix-Ranson L

PAYING FOR GENERAL PRACTIONERS: WHAT ARE THE RIGHT INCENTIVES?Franc C, de Pouvourville G

THE EFFICIENCY OF TREATMENT OF AUSTRIAN PHYSICIANS: A MALMQUISTINDEX APPROACHStaat M

A Del PS8 DRUGS PRESCRIPTION ANDEXPENDITURE

Chair:FAGNANI F(CEMKA)

A PANEL DATA ANALYSIS OF THE REGIONAL FACTORS AFFECTING ON DRUGCOSTS IN FINLANDMikkola H, Hakkinen U

DIFFUSION OF MULTIPLE THERAPIES COMBINATIONS FOR HIV PATIENTS:THE CONTRIBUTION OF LONGITUDINAL HIERARCHICAL LINEAR MODELFlori Y-A, Le Vaillant M

METHODOLOGICAL PROBLEMS MATCHING OBSERVATIONS OF GOODPRESCRIBING PRACTICES: BY WAY OF A STUDY CONDUCTED IN FRANCE FORTHE PRESCRIPTION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI)Sailly J-C, Gasquet I, Lenne X, Martinez L, Regnauld M-H

PHARMACEUTICAL USE AND EXPENDITURE FOR CARDIOVASCULAR DISEASEAND STROKE : A STUDY OF 12 OECD COUNTRIESJacobzone S

RT209 PS13 HEALTH CARE DETERMINANTS,WORK AND LIVING CONDITIONS

Chair:SANDIER S(ARgSES - Paris)

HEALTH IMPACTS OF THE NEW DEAL FOR YOUNG PEOPLE IN BRITAINBonjour D, Lakey J

TO WHICH EXTENT ARE HEALTH INEQUALITIES AVOIDABLECosta J, Garcia J

WORK AND HEALTH: WORKING CONDITIONS, JOB REQUIREMENTS,INDIVIDUAL HABITS, AND SICKNESS RISKAndren D, Andren T

25



PROGRAMME


A Pol PS19 HEALTH INSURANCE AND RISKADJUSTMENT

Chair:EECKHOUDT L(FUCAM – University of Mons)

CONSUMER MOBILITY AND RISK ADJUSTMENT ON A COMPETITIVE HEALTHINSURANCE MARKETVan de Voorde C, Schokkaert E

HEALTH-INSURER SPECIFIC DIFFERENCES IN HEALTH EXPENDITURE INBELGIUM : A MULTILEVEL MODELLING APPROACHRuz Torres R

INNOVATION AND RISK SELECTION IN DEREGULATED SOCIAL HEALTHINSURANCELehmann H, Zweifel P

LONG-TERM CARE INSURANCE AND BASIS RISKCourbage C

RT208 PS26 MICROECONOMIC ANALYSIS OFHEALTH BEHAVIOR

Chair:JOËL M-E(Université Paris IX-Dauphine)

EXPENDITURES OF TIME AND MONEY ON HEALTH: HOW DO THEY AFFECTWELL-BEING?Bednarek H, Pecchenino R-A, Stearns S-C

INFORMAL CARE PROVIDED BY SPOUSE AND CHILDREN FOR FRAILELDERLY: DO MICRO-ECONOMIC COMPONENTS MATTER ?Gramain A, Cozette E

VALUATION OF INFORMAL CARE: THE CONTINGENT VALUATION METHODVan Den Berg B, Brouwer W, Koopmanschap M, Van Exel J


26

CONFERENCE

€

27

INDEX OF SESSIONSPlenary SessionsPLS1: Healthcare Reorganization and the Future of European Growth . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 9.15-10.45 . . . . . . . . . . . . p. 9PLS2: Economic growth and health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 9.15-10.45 . . . . . . . . . . . . p. 9PLS3: American Health Care in the 1990s: Some Lessons for Europeans . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 11.00-12.30 . . . . . . . . . . p. 23PLS4: Evaluation and Policy making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 11.00-12.30 . . . . . . . . . . p. 23

Organised SessionsOS1: Payments to doctors in ambulatory care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 14.30-16.00 . . . . . . . . . p. 25OS2: Regional Health care in a Federal Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 9.00-10.30 . . . . . . . . . . . . p. 15OS3: The efficient production of health care in Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 9.00-10.30 . . . . . . . . . . . p. 22OS4: Integration / Coodination in the health care system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 9.00-10.30 . . . . . . . . . . . . p. 15OS5: Pricing and patenting regulations of drugs in Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 11.00-12.30 . . . . . . . . . . . p. 16OS6a: Health care systems in transition–Countries of Central and Eastern Europe – I . . . . . . . . . Mon. 8 July - 14.30-16.00 . . . . . . . . . . . p. 12OS6b: Health care systems in transition–Countries of Central and Eastern Europe – II. . . . . . . . . Mon. 8 July - 16.30-18.00 . . . . . . . . . . . p. 13OS7: Bayesian approach. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 14.30-16.00 . . . . . . . . . . . p. 19OS8: Economic evaluation at an international level . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 16.30-18.00 . . . . . . . . . . . p. 13OS9: Risk adjustment in health economics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 14.30-16.00 . . . . . . . . . . . p. 12OS10: Microeconomic approaches for understanding the physician-patient encounter . . . . . . . . Tues. 9 July - 14.30-16.00 . . . . . . . . . . . p. 19OS11: Cost of ageing and cost of dying . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 11.00-12.30 . . . . . . . . . . . p. 16OS12: Taxation and addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 11.00-12.30 . . . . . . . . . . . p. 17OS13: Free choice of sickness funds in regulated competition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 14.30-16.00 . . . . . . . . . . . p. 19OS14: Performance measurement of health care organisations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 11.15-12.45 . . . . . . . . . . . p. 9OS15: Effect of ownership and management on providers' performance . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 16.30-18.00 . . . . . . . . . . . p. 20OS16: Risk perception and prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 9.00-10.30 . . . . . . . . . . . . p. 15

Parallel SessionsPS1: Axiomatic foundations of outcomes measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 16.30-18.00 . . . . . . . . . . . p. 13PS2: Competition and regulation of health care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 11.00-12.30 . . . . . . . . . . . p. 17PS3: Cost studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 9.00-10.30 . . . . . . . . . . . . p. 15PS4: Decision making, equity and priority setting in health care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 9.00-10.30 . . . . . . . . . . . p. 22PS5: Drug and tobacco addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 11.15-12.45 . . . . . . . . . . . p. 9PS6: Drugs and regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 14.30-16.00 . . . . . . . . . . . p. 19PS7: Drugs market : Structure, pricing and advertising . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 16.30-18.00 . . . . . . . . . . . p. 20PS8: Drugs prescription and expenditure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 14.30-16.00 . . . . . . . . . p. 25PS9: Economic evaluation study I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 11.15-12.45 . . . . . . . . . . . p. 9PS10: Economic evaluation study II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 9.00-10.30 . . . . . . . . . . . p. 22PS11: Effects of supplementary health insurance on health care consumption . . . . . . . . . . . . . . . . Mon. 8 July - 16.30-18.00 . . . . . . . . . . . p. 14PS12: Health care demand . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 11.15-12.45 . . . . . . . . . . . p. 10PS13: Health care determinants, work and living conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 14.30-16.00 . . . . . . . . . p. 25PS14: Health care expenditure and ageing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 11.15-12.45 . . . . . . . . . . . p. 10PS15: Health care organisation and coordination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 16.30-18.00 . . . . . . . . . . . p. 21PS16: Health care system performance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 14.30-16.00 . . . . . . . . . . . p. 12PS17: Health determinants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 9.00-10.30 . . . . . . . . . . . p. 23PS18: Health in Central and Eastern Europe countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 14.30-16.00 . . . . . . . . . . . p. 20PS19: Health insurance and risk adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 14.30-16.00 . . . . . . . . . p. 26PS20: Health professionals and incentives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 9.00-10.30 . . . . . . . . . . . p. 23PS21: Health workforce planning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 16.30-18.00 . . . . . . . . . . . p. 14PS22: Health, health expenditure and economic growth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 14.30-16.00 . . . . . . . . . . . p. 12PS23: Hospital financing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 9.00-10.30 . . . . . . . . . . . . p. 16PS24: Methodology of economic evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 16.30-18.00 . . . . . . . . . . . p. 21PS25: Methodology of preference elicitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 11.00-12.30 . . . . . . . . . . . p. 17PS26: Microeconomic analysis of health behaviour . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 14.30-16.00 . . . . . . . . . p. 26PS27: Performance measurement of organisation I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 14.30-16.00 . . . . . . . . . . . p. 20PS28: Performance measurement of organisation II : DEA Method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 16.30-18.00 . . . . . . . . . . . p. 21PS29: Public / Private mix of health insurance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 11.15-12.45 . . . . . . . . . . . p. 10PS30: Regional Health care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 11.00-12.30 . . . . . . . . . . . p. 17PS31: Risk adjustment for health care financing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 16.30-18.00 . . . . . . . . . . . p. 21PS32: Treatment choice and provider incentives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 9.00-10.30 . . . . . . . . . . . p. 23PS33: Willingness to pay I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 14.30-16.00 . . . . . . . . . . . p. 13PS34: Willingness to pay II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 9.00-10.30 . . . . . . . . . . . . p. 16

Poster SessionsPOS I: Poster session I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mon. 8 July - 13.30-14.30 . . . . . . . . . . . p. 11POS II: Poster session II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tues. 9 July - 13.30-14.30 . . . . . . . . . . . p. 18POS III:Poster session III . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Wed. 10 July - 13.30-14.30 . . . . . . . . . p. 24



PROGRAMME


7, rue de Cîteaux - 75012 Paris - FranceTél. : +33 (0)1 43 45 75 65 - Fax : +33 (0)1 43 45 75 67

E.mail : [email protected] ou [email protected]://perso.wanadoo.fr/ces/

conference programme - collège des … european conference on health economics collÈge des...

Documents